Purpose: Accurate prediction of lymph node (LN) status is of crucial importance for appropriate treatment planning in early gastric cancer (EGC). Matrix metalloproteinases (MMPs) have been shown to be involved in the pathogenesis of tumor progression and metastasis in gastric carcinoma. In this study, we investigated the association between MMPs expressions and LN metastasis in EGC. Methods: Thirty-four LN positive and 80 LN negative pT1 tumors were immunohistochemically analyzed for MMP-2, MMP-7, and MMP-9 expression. The relation of MMPs expressions to LN metastasis was analyzed in the univariate and multivariate model. Results: There were 73 men and 41 women with a mean age of 60 years. Among the pathologic characteristics, larger tumor size, submucosal invasion and lymphatic invasion were factors that are significantly associated with LN metastasis in pT1 tumors. Immunohistochemistry showed significantly higher MMP-7 expression (82.4% vs. 54.4%, P=0.005) in LN positive tumors, whereas MMP-9 (85.3% in LN positive vs. 67.5% in LN negative) and MMP-2 (70.6% in LN positive vs. 57.5% in LN negative) expression did not reach statistical significance. Multivariate analysis revealed that MMP-7 expression (OR 4.915, 95% CI 1.375∼17.573) is an independent predictor of LN metastasis in EGCs, along with lymphatic invasion by tumor cells (OR 10.337, 95% CI 2.785∼ 38.360). Conclusion: Our study shows that MMP-7 expression is significantly associated with LN metastasis in EGC. MMP-7 expression can be used to predict LN status in EGCs in addition to other pathological parameters. 
INTRODUCTION
Hospital. Of these, 34 (6.6%) cases had LN metastasis at final pathologic examinations and were included in this study. Eighty EGC patients without LN metastasis were collected at random and used as controls. All patients underwent standard gastrectomy including distal or total gastrectomy with limited or extended LN dissection.
Gastric cancer samples were obtained with informed consent from the Chonnam National University Hwasun.
2) Histopathology
After resection, all specimens were fixed in 10% buffered formalin, embedded in paraffin wax, and serially sectioned at 3∼5 mm. Sections were stained with hematoxylin and eosin (H&E) and subjected to pathological examination, at which depth of invasion, lymph node metastasis, histologic type, Lauren's classification, and lymphovascular permea- 
3) Immunohistochemistry
Tissue sections from formalin-fixed, paraffin-embedded blocks were deparaffinized with xylene, rehydrated through graded ethanol, rinsed with distilled water, and washed with Tris-buffered saline (TBS). Antigen retrieval was performed by boiling for 20 min in citrate buffer (pH 6.0).
Avidin-biotin-peroxidase complex staining using DAB as a chromogen was performed using a standard technique, as described by the manufacturer (Dako, Glostrup, Denmark).
The primary antibodies used were rabbit anti-MMP-2 (1： 100, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-MMP-9 (1：100, Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-MMP-7 (1：75, Chemicon), mouse anti-CK (1：100, Dako, Glostrup, Denmark), and mouse anti-D2-40 (1：50, Dako, Glostrup, Denmark).
4) Evaluation of immunostaining
Staining for MMP-2, MMP-7, and MMP-9 at the invasive front were evaluated by two independent researchers (JH Lee and YK Park) without knowledge of clinicopathological data, and staining intensities (stains were dark brown in color) were graded as: 0, negative; 1＋, weak staining; 2＋, moderate; and 3＋, strong. MMP immunostaining was deemed positive when moderate to 10.0%, P＜0.001) in the LN positive group.
2) Immunohistochemistry
Immunohistochemistry showed MMP-7 expression in 28 (82.4%) of the 34 LN positive pT1 tumor samples, which was significantly higher than that in the LN negative group (82.4% vs. 54.4%, P=0.005) ( Table 2) . MMP-7 expression was observed in the cytoplasm and cell membranes of tumor cells, especially in deeper part of the tumor regions, namely at the invasive front (Fig. 1) . MMP-9 expression was also greater in the LN positive group, but with marginal statistical significance (85.3% vs. 67.5%, P=0.051).
Fig. 1. Representative histologic and immunohistochemical staining images of MMP-7 in pT1 gastric cancer with and without lymph node metastasis. Note that MMP-7 was immunostained in carcinoma cells at invasive fronts and in tumor budding cells in pT1 tumor with nodal metastasis (A), whereas no staining was observed in tumor cells at invasive fronts in pT1 tumor without nodal metastasis (B). Cytokeratin (CK) staining was used to improve the visualization of small numbers of tumor cells budding from invasive edges.
The solid line indicates the invasive front. Magnification=200×, scale bars=100μm. However, no significant inter-group difference was found for MMP-2 expression (70.6% in LN positive group vs.
57.5% in LN negative group, P=0.189).
3) Predicting factors for lymph node metastasis
To identify predicting factors for LN metastasis in pT1 tumors, variables found to be significantly associated with LN metastasis in histopathological examinations and IHC, such as, tumor size, submucosal invasion, lymphatic invasion, and MMP-7 expression, were subjected to univariate and multivariate analysis ( 
p53 expression,(5) erbB-2 expression,(6) DNA ploidy, (7) and VEGF expression, (8) are good examples that have been shown to be associated with LN metastasis in EGC. In this study, although sample size is small, we found that MMP-7 expression is also associated with LN metastasis in EGC.
In our analysis, MMP-7 expression remained as an independent predicting factor for LN metastasis even after adjusting other pathologic parameters. To our best knowledge, this study is the first to demonstrate the relation of MMP-7 expression to LN metastasis in EGC.
MMP-7 has broad-spectrum proteolytic activity against a variety of ECM substrates, including type IV collagens, proteoglycans, laminin, fibronectin, and casein. shown to be associated with tumor invasiveness and survival in gastric cancer, and its expression has also been associated with initial gastric cancer invasion. (17) Therefore, considering small sample size of our study, we think we need more studies with larger patients to investigate the association of MMP-2 and MMP-9 with LN metastasis in EGC.
Summarizing, the present study shows that MMP-7 expression is associated with LN metastasis in EGC, which
suggests that MMP-7 may have an important role during the early stages of LN metastasis in gastric cancer. Our results suggest that MMP-7 expression can be used as a molecular-pathologic marker for predicting LN metastasis in EGC.
